Back to search

Article

Inhibition of HIF-1α accumulation in prostate cancer cells is initiated during early stages of mammalian orthoreovirus infection

2020-09-02

Abstract excerpt

<h4>ABSTRACT</h4> Mammalian orthoreovirus (MRV) is a safe and effective cancer killing virus that has completed Phase I-III clinical trials against numerous cancer types. While many patients experience benefit from MRV therapy, pre-defined set points necessary for FDA approval have not been reached. Therefore, additional research into MRV biology and the effect of viral therapy on different tumor genetic subtypes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
565d1168-2434-5498-957f-8b60c1b9eb6c
DOI
10.1101/2020.09.02.279810
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhibition of HIF-1α accumulation in prostate cancer cells is initiated during early stages of mammalian orthoreovirus infectionDOI 10.1101/2020.09.02.279810
Select a neighboring publication to make it the new centre.